Cargando…
The macrolide drug erythromycin does not protect the hERG channel from inhibition by thioridazine and terfenadine
The macrolide antibiotic erythromycin has been associated with QT interval prolongation and inhibition of the hERG‐encoded channels responsible for the rapid delayed rectifier K(+) current I((Kr)). It has been suggested that low concentrations of erythromycin may have a protective effect against hER...
Autores principales: | El Harchi, Aziza, Butler, Andrew S., Zhang, Yihong, Dempsey, Christopher E., Hancox, Jules C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061092/ https://www.ncbi.nlm.nih.gov/pubmed/32147975 http://dx.doi.org/10.14814/phy2.14385 |
Ejemplares similares
-
Molecular basis of hERG potassium channel blockade by the class Ic antiarrhythmic flecainide
por: Melgari, Dario, et al.
Publicado: (2015) -
Inhibition of the hERG Potassium Channel by a Methanesulphonate-Free E-4031 Analogue
por: Helliwell, Matthew V., et al.
Publicado: (2023) -
Ranolazine inhibition of hERG potassium channels: Drug–pore interactions and reduced potency against inactivation mutants
por: Du, Chunyun, et al.
Publicado: (2014) -
Structural implications of hERG K(+) channel block by a high-affinity minimally structured blocker
por: Helliwell, Matthew V., et al.
Publicado: (2018) -
Suppression of the hERG potassium channel response to premature stimulation by reduction in extracellular potassium concentration
por: Melgari, Dario, et al.
Publicado: (2014)